People on the Move Archives - Page 2 of 145

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Agilent Awards UC Davis Researcher for Pioneering Work in Peptide Therapeutics

November 12, 2025

Drive Health Appoints Dr. Matthew Crowson as Chief Medical Officer

November 12, 2025

PepGen Receives U.S. Patent for Proprietary PGN-EDODM1 Molecule

November 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Trinity Appoints Scott Evangelista as CEO to Lead Next Phase of Growth

AdvanCell Appoints Philina Lee, PhD, as Chief Executive Officer to Lead U.S. Expansion and Drive Global Growth

Sensus Healthcare Expands Role of President Michael Sardano to Chief Commercial Officer

Drive Health Appoints Dr. Matthew Crowson as Chief Medical Officer

Tandem Diabetes Care Appoints Sandra Beaver to Board of Directors

Most Read

Caranx Medical Announces First Clinical Use of TAVIPILOT Soft, the World’s First AI Software for Real-Time Intra-Operative Guidance of Transcatheter Heart Valve Implantation

From the Science of Life to the Science of Skin: AV Laboratories Unveils Molecular Biotechnology Approach to Cellular Renewal

Acuitas Therapeutics Showcases Next-Generation Lipid Nanoparticle Technologies at 2025 mRNA Health Conference

Solve Therapeutics Secures $120 Million to Advance Best-in-Class ADCs for Solid Tumors

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Agilent Awards UC Davis Researcher for Pioneering Work in Peptide Therapeutics

Drive Health Appoints Dr. Matthew Crowson as Chief Medical Officer

PepGen Receives U.S. Patent for Proprietary PGN-EDODM1 Molecule

POPULAR CATEGORY

ABOUT US

FOLLOW US